Department of General, Visceral, Thoracic, Transplant and Pediatric Surgery, University Hospital of Giessen, Giessen, Germany.
Hernia. 2021 Apr;25(2):479-489. doi: 10.1007/s10029-020-02147-0. Epub 2020 Feb 29.
Morgagni-Larrey congenital diaphragmatic hernia (MLH) is rare in adult patients and surgery is performed infrequently. The evidence regarding the most beneficial treatment modality is low. Nevertheless, with increasing experience in minimally-invasive surgery, the literature proves the laparoscopic approach as being safely feasible. However, knowledge on the disease as well as treatment options are based on single surgeon's experiences and small case series in the literature.
Retrospective single-center analysis on adult patients (≥ 18 years) with MLH from 01/2003 to 06/2019 regarding symptoms, hernia sac contents, surgical technique and perioperative outcome.
4.0% of diaphragmatic hernia repair procedures were performed for MLH (n = 11 patients). 27.3% of these patients were asymptomatic. Dyspnea or gastrointestinal symptoms were frequently observed (both in 45.5% of the patients). Colon transversum (63.6%), omentum majus (45.5%) and/or stomach (27.3%) were the most common hernia sac contents. Correct diagnosis was achieved preoperatively in 10/11 patients by cross-sectional imaging. All procedures were performed by trans-abdominal surgery (laparotomy in four and laparoscopy in seven patients). All hernias were reinforced by mesh after primary closure. No differences were observed in the perioperative outcome between patients who underwent hernia repair by laparotomy versus laparoscopy. Pleural complications requiring drainage were the most common postoperative complications.
MLH repair seems to be safely feasible by laparoscopic surgery. The benefit of mesh augmentation in MLH repair is not clear yet. In contrast to the current literature, all patients in this study received mesh augmentation after primary closure of the hernia. This should be evaluated in larger patient cohorts with long-term follow-up.
Morgagni-Larrey 先天性膈疝(MLH)在成年患者中较为罕见,手术也很少进行。关于最有益的治疗方式的证据不足。尽管如此,随着微创技术经验的增加,文献证明腹腔镜方法是安全可行的。然而,对这种疾病以及治疗方案的了解是基于单个外科医生的经验和文献中的小病例系列。
回顾性分析 2003 年 1 月至 2019 年 6 月间,在我院接受 MLH 治疗的成年患者(≥18 岁)的症状、疝囊内容物、手术技术和围手术期结果。
膈疝修补术中有 4.0%是因 MLH 而进行的(n=11 例患者)。其中 27.3%的患者无症状。呼吸困难或胃肠道症状较常见(均为 45.5%的患者)。疝囊内容物最常见的是结肠横部(63.6%)、大网膜(45.5%)和/或胃(27.3%)。10/11 例患者通过横断面成像在术前获得了正确的诊断。所有手术均通过经腹手术(4 例行剖腹手术,7 例行腹腔镜手术)完成。所有疝均在一期修补后用网片加固。剖腹手术与腹腔镜手术治疗疝修补的围手术期结果无差异。需要引流的胸腔并发症是最常见的术后并发症。
腹腔镜手术治疗 MLH 似乎是安全可行的。在 MLH 修补中使用补片增强的益处尚不清楚。与目前的文献相比,本研究中的所有患者在疝修补后均接受了补片增强。这应在具有长期随访的更大患者队列中进行评估。